2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside
Modify Date: 2024-01-11 15:52:27
2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside structure
|
Common Name | 2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside | ||
|---|---|---|---|---|
| CAS Number | 1612192-00-3 | Molecular Weight | 354.72 | |
| Density | 1.9±0.1 g/cm3 | Boiling Point | 556.4±60.0 °C at 760 mmHg | |
| Molecular Formula | C14H12ClFN4O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 290.3±32.9 °C | |
Use of 2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2-Chloro-9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(2-furyl)-9H-purine |
|---|---|
| Synonym | More Synonyms |
| Description | 2-Chloro-6-(furan-2-yl) purine-beta-D-(3’-deoxy-3’-fluoro)-riboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 556.4±60.0 °C at 760 mmHg |
| Molecular Formula | C14H12ClFN4O4 |
| Molecular Weight | 354.72 |
| Flash Point | 290.3±32.9 °C |
| Exact Mass | 354.053101 |
| LogP | 1.96 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.777 |
| 9H-Purine, 2-chloro-9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(2-furanyl)- |
| 2-Chloro-9-(3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-(2-furyl)-9H-purine |